Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-19FDA Approved: OXYBUTYNIN CHLORIDE EXTENDED RELEASE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for oxybutynin chloride extended-release filed by Rising Pharma Holdings, Inc. This approval mak…
-
FDA approval · 2019-08-19FDA Approved: TOLTERODINE TARTRATE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' tolterodine tartrate as an original generic application, making tolterodine tartrate available as a generi…
-
FDA approval · 2019-08-13FDA Approved: FESOTERODINE FUMARATE — Original Application (Dr.Reddy's Laboratories Inc.,)
The FDA approved fesoterodine fumarate from Dr. Reddy's Laboratories Inc. via an original ANDA for the treatment of overactive bladder sympt…
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children [Phase 3]
Phase 3 trial update for fesoterodine and oxybutynin XR in children with overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children. [Phase 3]
Extension study update for fesoterodine in children with overactive bladder, Phase 3, completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Lidocaine for Pain After Urodynamic Testing [Phase 4]
Phase 4 clinical trial evaluating lidocaine for pain relief following urodynamic testing.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Controlling Urgency Through Relaxation Exercises [NA]
Completed clinical trial evaluating relaxation exercises to control urgency in patients with overactive bladder and urgency urinary symptoms…
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder [Phase 3]
Phase 3 trial update on GSK1358820 for overactive bladder reports results and safety data.
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder. [Phase 3]
Phase 3 trial comparing imidafenacin (Uritos) to tolterodine (Urotol) for overactive bladder has completed with posted results.
-
FDA approval · 2019-05-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Ascend Laboratories, LLC)
FDA approves Ascend Laboratories' generic solifenacin succinate under an original application. It is approved for overactive bladder.
-
FDA approval · 2019-05-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals' generic solifenacin succinate for overactive bladder via an original ANDA approval.
-
FDA approval · 2019-05-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's generic solifenacin succinate tablet under an original ANDA for the treatment of overactive bladder.
-
FDA approval · 2019-05-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approves the original application for solifenacin succinate (generic) for overactive bladder, supplied by ScieGen Pharmaceuticals, Inc.
-
FDA approval · 2019-05-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved a generic Solifenacin Succinate from Novadoz Pharmaceuticals LLC under an Original Application for the treatment of overactive …
-
FDA approval · 2019-05-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s solifenacin succinate as an Original Application (ANDA) for a generic version of the product. Solifena…
-
FDA approval · 2019-05-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Apotex Corp.)
The FDA approved Apotex Corp.'s original ANDA for solifenacin succinate, a generic treatment for overactive bladder, providing a non-brand o…
-
FDA approval · 2019-05-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Actavis Pharma, Inc.)
FDA approved a generic version of solifenacin succinate for overactive bladder under ANDA 202551. Actavis Pharma, Inc. is the applicant.
-
FDA approval · 2019-05-20FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Bostal LLC)
The FDA approved the original application for Solifenacin succinate by Bostal LLC, making a generic version available. Solifenacin succinate…
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Mirabegron in Parkinson Disease and Impaired Cognition [Phase 4]
Phase 4 clinical trial update on mirabegron in Parkinson disease and impaired cognition with completed status and results posted.
-
FDA approval · 2019-04-30FDA Approved: VESICARE — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for Vesicare (solifenacin succinate) submitted by Astellas Pharma US, resulting in updated label…
-
CLINICAL_TRIALS withdrawal · 2019-03-07Clinical Trial Update: Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome [Phase 4]
Phase 4 clinical trial evaluating a Beta-3 agonist for psychological distress and bladder blood flow in women with overactive bladder; the s…
-
FDA approval · 2019-02-28FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s oxybutynin chloride as an original ANDA (ANDA211655), a generic product.
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction [Phase 3]
Phase 3 clinical trial of Botox for overactive bladder due to benign prostatic obstruction has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms [Phase 4]
Phase 4 trial update on the timing of belladonna and opium suppositories to relieve post-operative bladder spasms in Overactive Bladder; the…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB) [Phase 4]
Phase 4 study evaluating efficacy, safety, and tolerability of mirabegron in older adults with overactive bladder has completed with results…